Barclays’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,000
| Closed | -$33K | – | 5074 |
|
|
2020
Q3 | $33K | Hold |
2,000
| – | – | ﹤0.01% | 4768 |
|
|
2020
Q2 | $34K | Sell |
2,000
-11,500
| -85% | -$170K | ﹤0.01% | 5066 |
|
|
2020
Q1 | $157K | Buy |
13,500
+9,400
| +229% | +$194K | ﹤0.01% | 4477 |
|
|
2019
Q4 | $114K | Buy |
+4,100
| New | +$103K | ﹤0.01% | 5406 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$14K | – | 7110 |
|
|
2019
Q1 | $14K | Buy |
+500
| New | +$16.8K | ﹤0.01% | 6466 |
|
|
2018
Q4 | – | Sell |
-1,600
| Closed | -$75K | – | 7156 |
|
|
2018
Q3 | $75K | Sell |
1,600
-12,700
| -89% | -$583K | ﹤0.01% | 5798 |
|
|
2018
Q2 | $619K | Buy |
14,300
+4,400
| +44% | +$211K | ﹤0.01% | 3747 |
|
|
2018
Q1 | $551K | Buy |
9,900
+8,100
| +450% | +$444K | ﹤0.01% | 3874 |
|
|
2017
Q4 | $96K | Buy |
+1,800
| New | +$84.9K | ﹤0.01% | 5273 |
|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$205K | – | 6965 |
|
|
2017
Q2 | $205K | Sell |
3,400
-100
| -3% | -$5.93K | ﹤0.01% | 4336 |
|
|
2017
Q1 | $243K | Sell |
3,500
-500
| -13% | -$34.7K | ﹤0.01% | 4122 |
|
|
2016
Q4 | $267K | Buy |
+4,000
| New | +$260K | ﹤0.01% | 3960 |
|
|
2016
Q3 | – | Sell |
-700
| Closed | -$51K | – | 6718 |
|
|
2016
Q2 | $51K | Sell |
700
-1,600
| -70% | -$110K | ﹤0.01% | 4818 |
|
|
2016
Q1 | $147K | Buy |
2,300
+800
| +53% | +$53.1K | ﹤0.01% | 4079 |
|
|
2015
Q4 | $107K | Buy |
1,500
+800
| +114% | +$59.2K | ﹤0.01% | 4363 |
|
|
2015
Q3 | $53K | Buy |
+700
| New | +$56.5K | ﹤0.01% | 4991 |
|
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$144K | – | 7123 |
|
|
2015
Q1 | $144K | Sell |
2,000
-900
| -31% | -$62.6K | ﹤0.01% | 4594 |
|
|
2014
Q4 | $191K | Buy |
2,900
+1,300
| +81% | +$79.3K | ﹤0.01% | 4674 |
|
|
2014
Q3 | $86K | Sell |
1,600
-500
| -24% | -$28.4K | ﹤0.01% | 5441 |
|
|
2014
Q2 | $121K | Sell |
2,100
-6,700
| -76% | -$394K | ﹤0.01% | 5273 |
|
|
2014
Q1 | $537K | Sell |
8,800
-2,600
| -23% | -$151K | ﹤0.01% | 3893 |
|
|
2013
Q4 | $604K | Buy |
11,400
+2,400
| +27% | +$129K | ﹤0.01% | 3908 |
|
|
2013
Q3 | $450K | Buy |
9,000
+6,800
| +309% | +$332K | ﹤0.01% | 4227 |
|
|
2013
Q2 | $101K | Buy |
+2,200
| New | +$98.5K | ﹤0.01% | 5775 |
|
Other funds holding MD
VPM
VCM
WA
Barclays's MD Position: Q1 2026 in Review
Barclays reduced its Pediatrix Medical (MD) stake by 72% in Q1 2026, selling an estimated $2.38M and leaving 44,235 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #2793.
Barclays first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.7M in Q2 2019. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Barclays held 44,235 shares of Pediatrix Medical worth $946K as of Q1 2026.
- Barclays sold 114,308 Pediatrix Medical shares in Q1 2026, an estimated $2.38M.
- Pediatrix Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2793 holding.
- Barclays first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Pediatrix Medical position peaked at $11.7M in Q2 2019.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.